When would it be clinically necessary to keep to a specific brand instead of generics?
To this question, I was thinking NTI drugs such as theophylline, biological products and modified release preparations.
But the categories that I have mentioned may be too broad. For example, digoxin, one of NTI-drugs, does not need to be
given in a specific brand.
Could you help me out?
And where would find information regarding this? SPCs?


Reply With Quote

